Evidence map›Paper›PMID 40325081›Full record

Trial reportScientific reports2025

Effects of integrated exercise approach on total testosterone levels in eumenorrheic women: a randomized controlled trial.

Wajiha Shahid, Rabiya Noor

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05460741 (Effects of Integrated Exercise Approach on Strength, Postural Stability and Biomarkers of Menstrual Cycle in Eumenorrheic Females), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05460741 nacompletednot on this map

Effects of Integrated Exercise Approach on Strength, Postural Stability and Biomarkers of Menstrual Cycle in Eumenorrheic Females

TypeinterventionalSponsorRiphah International UniversityRan2022 to 2024Enrolled60ConditionsFemales, Menstrual DiscomfortArmsintegrated exercise approach, educational program
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wajiha ShahidRiphah International University, Lahore, Pakistan.
Rabiya NoorRiphah International University, Lahore, Pakistan. wajishahid89@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testosterone modulated by exercise plays a pivotal role in maintaining the overall health of both males and females. Therefore, this study aimed to determine the effects of an integrated exercise approach on total testosterone levels during different phases of the menstrual cycle in eumenorrheic females. This was a two-armed parallel design, single-blinded, randomized controlled trial held from March 14, 2023, to February 21, 2024, in Aadil Hospital Defense Lahore. Forty eumenorrheic females within the age range of 20 to 40 years, with a BMI ranging from 18.5 to 24.9, who were able to maintain sitting balance without the need for upper limb support or who had a minimum score of 25 on the trunk control test were recruited for the study. They were then divided into 2 groups using a random table generator and concealed envelope allocation. The treatment group was given an exercise plan 3 times per week for 16 weeks along with an awareness program for menstrual hygiene and maintaining an active lifestyle, while the control group was given an awareness program to maintain menstrual hygiene and an active lifestyle along with a recommendation to walk for 30 min 3 times a week for 16 weeks. The testosterone levels were calculated pre-intervention, mid-intervention, and post-intervention. Mixed model ANOVA was used for within- and between-group analyses. The data were analyzed using SPSS v21. The educational backgrounds of the participants were diverse, with 17.5% having completed matric, 47.5% holding a bachelor's degree, and 17.5% having a master's degree or PhD. Regarding occupation, 35% were students, 32.5% were housewives, and 32.5% were working professionals. Marital status varied, with 37.5% married, 45% unmarried, and 17.5% divorced. Total testosterone levels (ng/dl) were measured at different menstrual cycles for the experimental and control groups. During the follicular phase, the experimental group showed pre-exercise levels of 25.80 ± 2.57 (95% CI: 24.24-27.35) and post-intervention levels within 15 min of exercise of 33.04 ± 8.67 (95% CI: 28.85-37.23). In the mid-cycle phase, the pre-exercise level was 36.48 ± 2.80 (95% CI: 33.47-37.48), and the post-intervention level was 40.80 ± 7.12 (95% CI: 37.15-44.46). The luteal phase showed pre-exercise levels of 31.10 ± 3.44 (95% CI: 29.90-34.31) and post-intervention levels within 15 min of exercise of 34.97 ± 5.60 (95% CI: 31.95-38.00). Compared with the experimental group, the control group exhibited consistent testosterone levels with minor variations across all phases. The mixed model ANOVA results for the between-group effect were highly significant, with p = 0.00 and an effect size of 0.99. Integrated exercise leads to an increase in testosterone levels in females immediately after exercise, which decreases below pre-exercise levels within 24 h of exercise, with the testosterone level peaking in the mid-cycle phase of the menstrual cycle. This immediate increase in testosterone levels can lead to increased strength, cognition and sexual functions in females.Trial registration number. This clinical trial was submitted by Dr. Rabiya Noor on clinicaltrials.gov for registration with ID: NCT05460741 first posted on 31/05/2022, last updated on 03/04/2024, and last verified on 29/04/2024.

Indexed as

ExerciseMenstrual CycleTestosteroneAdultFemaleHumansMenstruationSingle-Blind MethodYoung AdultTestosteroneEumenorrheicHormonesIntegrated exercisesMenstrual cyclePhysical activityTestosterone

Identifiers

PMID40325081
PMCPMC12053553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.